News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Amanda Yopp

Advertisement

Articles by Amanda Yopp

Amanda Yopp Discusses the Challenges With Treating Multiple Myeloma Patients

ByAmanda Yopp
June 15th 2015

Amanda Yopp, NP, Clinical Nurse Educator, Takeda Oncology, discusses the challenges with treating patients with multiple myeloma.

Advertisement

Latest Updated Articles

  • Amanda Yopp Discusses the Challenges With Treating Multiple Myeloma Patients
    Amanda Yopp Discusses the Challenges With Treating Multiple Myeloma Patients

    Published: June 15th 2015 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Greenlights Niraparib/Abiraterone Acetate With Prednisone in mHSPC

2

Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML

3

Pembrolizumab Plus RT Ups T-Cell Infiltration in Early Breast Cancer

4

Teclistamab/Daratumumab Increases OS, PFS in R/R Multiple Myeloma

5

Progression Occurs Early in R/R LBCL Treated With Epcoritamab, Glofitamab

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us